4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-25-004924
Options or other derivatives
- Director acquired 34,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McBride John S. · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-10 | Grant or award : show line 1 in the form Stock Option (right to buy) | +30,870 | 30,870 | D |
| 2025-01-10 | Grant or award : show line 2 in the form Restricted Stock Units | +3,430 | 3,430 | D |
Loading xslF345X05/ownership.xml…